DERM vs MCO · rev $34.5M vs P/E 33, rev $4.26B
Journey Medical Corp (DERM) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported DERM revenue for 2026-06-30 was $34.5M. Net income was -$2.5M. DERM currently screens at market cap $163.1M.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
DERM currently screens at market cap $163.1M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the DERM and MCO stock pages for the full models.
Not investment advice.